OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Jürgen Wess, Antwi‐Boasiako Oteng, Osvaldo Rivera‐Gonzalez, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 854-884
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Molecular basis of opioid receptor signaling
Tao Che, Bryan L. Roth
Cell (2023) Vol. 186, Iss. 24, pp. 5203-5219
Open Access | Times Cited: 38

Structure, function and drug discovery of GPCR signaling
Lin Cheng, Fan Xia, Ziyan Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 33

MRAP2 Inhibits β-Arrestin-2 Recruitment to the Prokineticin Receptor 2
Roberta Lattanzi, Ida Casella, Maria Rosaria Fullone, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 2, pp. 1607-1620
Open Access | Times Cited: 8

Pain Signaling by GPCRs and RTKs
B. Schmidt, Francesco De Logu, Romina Nassini, et al.
Trends in Pharmacological Sciences (2025)
Closed Access | Times Cited: 1

Non-canonical G protein signaling
Bernd Nürnberg, Sandra Beer‐Hammer, Ellen Reisinger, et al.
Pharmacology & Therapeutics (2024) Vol. 255, pp. 108589-108589
Open Access | Times Cited: 7

International Union of Basic and Clinical Pharmacology. CXV: The Class F of G Protein-Coupled Receptors.
Gunnar Schulte
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1009-1037
Closed Access | Times Cited: 7

Antagonism of β-arrestins in IL-4–driven microglia reactivity via the Samd4/mTOR/OXPHOS axis in Parkinson’s disease
Jiaqi Liu, Yue Liang, Qing‐Hao Meng, et al.
Science Advances (2024) Vol. 10, Iss. 34
Open Access | Times Cited: 5

LIPIDS MODULATE THE DYNAMICS OF GPCR:β-ARRESTIN INTERACTION
Antoniel Augusto Severo Gomes, Michela Di Michele, Rita Roessner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors
András Dávid Tóth, Gábor Turu, László Hunyady
Nature Reviews Nephrology (2024) Vol. 20, Iss. 11, pp. 722-741
Closed Access | Times Cited: 4

The Role of Individual Residues in the N-Terminus of Arrestin-1 in Rhodopsin Binding
Sergey A. Vishnivetskiy, TT Paul, Eugenia V. Gurevich, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 715-715
Open Access

From metabolic regulation to kidney protection: β-arrestin 2 as a dual-function therapeutic target
Jian Yang, Chengzhi Zhang, Jing Zhang
World Journal of Diabetes (2025) Vol. 16, Iss. 3
Closed Access

Canonical or non‐canonical, all aspects of G protein‐coupled receptor kinase 2 in heart failure
Abdullah Kaplan, Lana El‐Samadi, Rana Zahreddine, et al.
Acta Physiologica (2025) Vol. 241, Iss. 3
Open Access

Regulation of GLP-1 and Glucagon Receptor Function by β-Arrestins in Metabolically Important Cell Types
Liu Liu, Muhammad Rashid, Jürgen Wess
Biochemistry (2025)
Closed Access

Exploring a novel mechanism for targeting β-arrestin-2 in the management of diabetic nephropathy
Na Liu, Weitao Yan, Kun Xiong
World Journal of Diabetes (2025) Vol. 16, Iss. 4
Closed Access

Regulation of autophagy: Insights into O-GlcNAc modification mechanisms
Chengzhi Liu, Xinyu Wang, Shengnan Xu, et al.
Life Sciences (2025) Vol. 369, pp. 123547-123547
Closed Access

The Potential Capacities of FTY720: Novel Therapeutic Functions, Targets, and Mechanisms against Diseases
Juan Liu, Lu Zhang, Le Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117508-117508
Open Access

cFos-mediated β-Arrestin1 in the RVLM alleviates sympathetic hyperactivity induced by ovariectomy
Jiuqiong Yan, Meng Qi, Hao Fan, et al.
Molecular and Cellular Endocrinology (2025), pp. 112520-112520
Closed Access

β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma
Parker Mathews, Xiaobei Wang, Jian Wu, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 496-496
Open Access

Neurokinin 1 Receptor Endocytosis and Signaling
Francisco D. Rodríguez, Rafael Coveñas
˜The œReceptors (2025), pp. 325-346
Closed Access

SHU9119 and MBP10 are biased ligands at the human melanocortin-4 receptor
Han-Chuan Dai, Ren-Lei Ji, Ya‐Xiong Tao
Biochemical Pharmacology (2024) Vol. 228, pp. 116325-116325
Closed Access | Times Cited: 3

From membrane to nucleus: A three-wave hypothesis of cAMP signaling
Alejandro Pizzoni, Xuefeng Zhang, Daniel L. Altschuler
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105497-105497
Open Access | Times Cited: 7

Superior performance of biocomposite nanoparticles PLGA-RES in protecting oocytes against vitrification stimuli
Guiping Hai, Jiachen Bai, Yucheng Liu, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2

Generation of Comprehensive GPCR-Transducer-Deficient Cell Lines to Dissect the Complexity of GPCR Signaling
Ayaki Saito, Ryoji Kise, Asuka Inoue
Pharmacological Reviews (2024) Vol. 76, Iss. 4, pp. 599-619
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top